Phase II study of pegaspargase, etoposide, gemcitabine (PEG) followed by involved-field radiation therapy in early-stage extranodal natural killer/T-cell lymphoma

Phase II study of pegaspargase, etoposide, gemcitabine (PEG) followed by involved-field radiation therapy in early-stage extranodal natural killer/T-cell lymphoma

Objective: The prognosis of extra-nodal NK/T cell lymphoma (ENKTL) is poor, and the optimal therapy remains controversial. This study aims to evaluate the safety and efficacy of a new combined modality therapy.Methods: Phase-2 study of pegaspargase, etoposide and gemcitabine (PEG) combined with invo...

Full description

Saved in:
Bibliographic Details
Main Authors: Demei Feng, Zhimin Yan, Bibo Fu, Shenrui Bai, Lewei Zhu, Robert Peter Gale, Zhongjun Xia, Yang Liang, Hua Wang
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Hematology
Subjects:
Extra-nodal NK/T-cell lymphoma
pegaspargase
etoposide
gemcitabine
radiotherapy
Online Access:https://www.tandfonline.com/doi/10.1080/16078454.2024.2402102
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items